Position in MDXG
as of Mar 31, 2026
· filed Apr 15, 2026
Position Value
$287,133
-$222,471 QoQ
Shares Held
72,692
-3.4% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PARSONS CAPITAL MANAGEMENT INC/RI holds $8,271,929 across 6 Biotechnology names. MDXG ranks #5 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,641 | $4,305,092 | |
| 2 | RLMD |
Relmada Therapeutics, Inc.
|
352,500 | $2,453,400 | |
| 3 | NRXS |
Neuraxis, INC
|
116,726 | $863,772 | |
| 4 | TECH |
BIO-TECHNE Corp
|
6,852 | $358,085 | |
| 5 | MDXG |
Mimedx Group, Inc.
This page
|
72,692 | $287,133 | |
| 6 | GTBP |
GT Biopharma, Inc.
|
10,900 | $4,447 |
All Filings in MDXG
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $287,133 | 72,692 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $509,604 | 75,274 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $675,482 | 96,774 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $866,239 | 141,774 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $1,114,532 | 146,649 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,607,973 | 167,149 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $1,126,717 | 190,646 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,504,821 | 217,146 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,749,024 | 227,146 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $1,992,070 | 227,146 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $1,655,894 | 227,146 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $1,702,108 | 257,505 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,344,239 | 394,205 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $1,111,541 | 399,835 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,795,070 | 625,460 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $2,235,103 | 644,122 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $3,274,773 | 695,281 | Shares | Defined | 2022-05-02 | |
| 2021-12-31 | $4,250,837 | 703,781 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $4,460,202 | 736,007 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $9,917,802 | 792,790 | Shares | Defined | 2021-08-03 | |
| 2021-03-31 | $8,461,316 | 821,487 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $7,913,101 | 871,487 | Shares | Defined | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||